Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: May 28, 2009

Premium

Thermo Fisher Scientific named two new directors to its board this week, Thomas Lynch, and Tyler Jacks.

Lynch is the CEO of Tyco Electronics. He previously held management positions at Motorola and General Instrument. In April 2008, he was appointed to President Bush's National Security Telecommunications Advisory Committee.

Jacks is the David H. Koch professor of biology at the Massachusetts Institute of Technology where he is also the director of the David H. Koch Institute for Integrative Cancer Research. He was director of the MIT Center for Cancer Research from 2001 to 2008.


Strategic Diagnostics announced this week Kevin Bratton has joined the company as vice president of finance and Chief Financial Officer, effective June 1.

Bratton joins SDI from EUSA Pharma where he was senior vice president of business operations. Before that he was senior vice president and CFO of Cytogen before it was acquired by EUSA.


Caris Diagnostics announced this week the appointment of David Loesch as director of oncology, clinical trials, and services.

Loesch has been a practicing medical oncologist for more than 18 years and served as co-chairman of the Breast Cancer Committee of the US Oncology Network.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.